8-K: SurgePays Gets Nasdaq Delisting Reprieve

SurgePays, Inc. has received an additional 180-day extension from Nasdaq to regain compliance with the minimum $1.00 bid price requirement, now until March 22, 2027.

Summary

• SurgePays, Inc. received a letter from Nasdaq on September 28, 2026, granting an additional 180-day period, until March 22, 2027, to meet the minimum $1.00 bid price per share requirement.
• This extension follows a previous notification on March 23, 2026, and an initial compliance period that ended September 21, 2026.
• Nasdaq granted the extension because the company meets other listing requirements, including market value of publicly held shares, and has indicated an intention to cure the deficiency, potentially through a reverse stock split.
• In a separate notification on September 28, 2026, Nasdaq confirmed that SurgePays complies with the minimum stockholders equity requirement.
• Failure to regain compliance by March 22, 2027, will result in a delisting notification, though an appeal to a Nasdaq Hearings Panel is possible.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the continued risk of delisting, despite a temporary extension.

Positives

• Granted an additional 180-day compliance period until March 22, 2027, to address the bid price deficiency.
• Meets the continued listing requirement for market value of publicly held shares.
• Has indicated an intention to cure the deficiency, potentially through a reverse stock split.
• Complies with the minimum stockholders equity requirement under Nasdaq Listing Rule 5550(b)(1).

Negatives

• Still faces a deficiency in the minimum $1.00 bid price per share requirement.
• Failure to regain compliance by March 22, 2027, will lead to delisting.
• There is no assurance that compliance will be regained or maintained.
• Potential delisting could reduce stock liquidity and market price.
• Delisting may hinder the company's ability to raise equity financing.
• Delisting could limit the company's ability to use registration statements for public offerings.
• Delisting may impair the company's ability to provide equity incentives to employees.

Risks

• Risk of delisting from The Nasdaq Stock Market if the minimum $1.00 bid price per share requirement is not met by March 22, 2027.
• Potential negative impact on stock liquidity and market price if delisted.
• Reduced ability to raise equity financing due to delisting.
• Limited ability to access public capital markets if delisted.
• Impaired ability to offer equity incentives to employees if delisted.
• The company remains subject to other applicable Nasdaq listing requirements.

Future Outlook

The company has until March 22, 2027, to regain compliance with Nasdaq's minimum $1.00 bid price per share requirement, potentially through a reverse stock split. Failure to do so will result in delisting, although an appeal process exists. The company also needs to ensure compliance with other listing requirements upon filing its next periodic report.

Management Comments

• The Company may appeal that determination to a Nasdaq Hearings Panel; however, a timely request for a hearing following the expiration of the second 180-day compliance period would not stay the suspension of trading in the Companys securities.

Industry Context

StockSavvy.ai notes that maintaining Nasdaq listing is crucial for many growth-oriented companies, impacting investor confidence, access to capital, and valuation. Companies facing bid price deficiencies often explore reverse stock splits as a strategy to meet requirements, though this can be viewed negatively by the market if not accompanied by fundamental business improvements.

Stakeholder Impact

• Shareholders: Reduced liquidity and market price of common stock, potential difficulty in raising equity financing, and negative impact on equity incentives.
• Employees: Impaired ability to provide equity incentives.
• Investors: Reduced willingness to hold or acquire stock, potentially impacting future investment decisions.

Next Steps

• Regain compliance with Nasdaq's minimum $1.00 bid price per share requirement by March 22, 2027.
• Consider effecting a reverse stock split if necessary to cure the bid price deficiency.
• Ensure compliance with all other Nasdaq listing requirements upon filing the next periodic report.
• Prepare for potential appeal to a Nasdaq Hearings Panel if delisting notification is issued.

Key Dates

Recommendation

The company has been granted an extension to address its bid price deficiency, which is a positive short-term development. However, the underlying issue of not meeting the minimum bid price persists, and the threat of delisting remains significant. The company's ability to execute a successful strategy to regain compliance, potentially via a reverse stock split, is uncertain. Therefore, a 'hold' recommendation reflects the balance between the temporary reprieve and the ongoing risks.

Keywords

Nasdaq compliance, bid price deficiency, delisting risk, reverse stock split, listing requirements, stockholder equity, publicly held shares